Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Drug Resistance
Biotech
Racing resistance, Novartis plans pivotal malaria drug trial
The solid dispersion formulation is entering phase 3 on the strength of evidence it may kill drug-resistant forms of the parasite.
Nick Paul Taylor
Nov 23, 2022 7:20am
Multidrug-resistant pathogen targets RNA of competitor bacteria
Sep 7, 2022 5:11pm
Boehringer rounds up allies to build €40M anti-superbug startup
Jul 6, 2022 6:01am
New antiviral class could halt treatment-resistant viruses
May 16, 2022 3:10pm
Lack of policy, investment stifling antibiotics pipeline
Apr 12, 2022 9:00am
Fighting drug-resistant cancer by blocking an escape route
Jan 5, 2022 8:35am
